The Totality of Evidence and Use of ABP 215, a Biosimilar...

  • Main
  • 2020 / 12
  • The Totality of Evidence and Use of ABP 215, a Biosimilar...
Oncology and Therapy 2020 / 12

The Totality of Evidence and Use of ABP 215, a Biosimilar to Bevacizumab

Goldschmidt, Jerome, Hanes, Vladimir
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Oncology and Therapy
DOI:
10.1007/s40487-020-00133-1
Date:
December, 2020
File:
PDF, 911 KB
2020
Conversion to is in progress
Conversion to is failed